Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 19.15% is 25% below its 5-year average of 25.50%, around the middle of its 5-year range (-14.37%–42.64%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.11% below its 12-month average of 28.20%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
19.15%
EBITDA MARGIN AVG TTM
28.20%
EBITDA MARGIN AVG 3Y
26.21%
EBITDA MARGIN AVG 5Y
25.50%
EBITDA MARGIN AVG 10Y
24.00%
EBITDA MARGIN AVG 15Y
21.70%
EBITDA MARGIN AVG 20Y
20.78%
CURRENT VS TTM AVG
-32.11%
CURRENT VS 3Y AVG
-26.95%
CURRENT VS 5Y AVG
-24.92%
CURRENT VS 10Y AVG
-20.22%
CURRENT VS 15Y AVG
-11.76%
CURRENT VS 20Y AVG
-7.87%
Market Cap
$24.03B
EBITDA Margin
-147.07%
TTM Avg
-132.24%
3Y Avg
-66.39%
5Y Avg
-46.73%
Market Cap
$24.54B
EBITDA Margin
27.93%
TTM Avg
16.21%
3Y Avg
17.95%
5Y Avg
14.24%
Market Cap
$21.88B
EBITDA Margin
50.36%
TTM Avg
50.37%
3Y Avg
51.80%
5Y Avg
47.75%
Market Cap
$24.72B
EBITDA Margin
24.13%
TTM Avg
25.03%
3Y Avg
27.36%
5Y Avg
27.53%
Market Cap
$26.21B
EBITDA Margin
19.69%
TTM Avg
19.16%
3Y Avg
18.89%
5Y Avg
21.02%
Market Cap
$26.46B
EBITDA Margin
15.75%
TTM Avg
14.53%
3Y Avg
14.10%
5Y Avg
17.90%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $23.22B | 19.15% | 28.20% | 26.21% | 25.50% |
| BioNTech SE (BNTX)vs › | $23.31B | -9.29% | -23.11% | 12.60% | 20.38% |
| Moderna, Inc. (MRNA)vs › | $24.03B | -147.07% | -132.24% | -66.39% | -46.73% |
| Incyte Corporation (INCY)vs › | $24.54B | 27.93% | 16.21% | 17.95% | 14.24% |
| United Therapeutics Corporation (UTHR)vs › | $21.88B | 50.36% | 50.37% | 51.80% | 47.75% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.72B | 24.13% | 25.03% | 27.36% | 27.53% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.21B | 19.69% | 19.16% | 18.89% | 21.02% |
| Labcorp Holdings Inc. (LH)vs › | $26.46B | 15.75% | 14.53% | 14.10% | 17.90% |
| Viatris Inc. (VTRS)vs › | $18.96B | 0.95% | 10.32% | 17.98% | 18.96% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.80B | 29.84% | 29.78% | 28.27% | 25.91% |
Gross Margin
44.0%
EBITDA Margin
19.1%
Operating Margin
18.8%
Net Margin
13.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 19.15% |
| 2026-03-31 | 42.64% |
| 2025-12-31 | 26.27% |
| 2025-09-30 | 26.69% |
| 2025-06-30 | 26.27% |
| 2025-03-31 | 22.86% |
| 2024-12-31 | 27.08% |
| 2024-09-30 | 25.20% |
| 2024-06-30 | 23.31% |
| 2024-03-31 | 34.02% |
| 2023-12-31 | 28.29% |
| 2023-09-30 | 27.77% |
| 2023-06-30 | 28.37% |
| 2023-03-31 | 26.55% |
| 2022-12-31 | 27.04% |
| 2022-09-30 | -14.37% |
| 2022-06-30 | 25.70% |
| 2022-03-31 | 26.90% |
| 2021-12-31 | 26.51% |
| 2021-09-30 | 19.59% |
| 2021-06-30 | 10.11% |
| 2021-03-31 | 23.48% |
| 2020-12-31 | 25.20% |
| 2020-09-30 | 25.88% |
| 2020-06-30 | 24.63% |
| 2020-03-31 | 25.36% |
| 2019-12-31 | 24.79% |
| 2019-09-30 | 23.94% |
| 2019-06-30 | 22.56% |
| 2019-03-31 | 24.88% |
| 2018-12-31 | 21.87% |
| 2018-09-30 | 22.49% |
| 2018-06-30 | 22.12% |
| 2018-03-31 | 22.08% |
| 2017-12-31 | 22.35% |
| 2017-09-30 | 22.72% |
| 2017-06-30 | 21.22% |
| 2017-03-31 | 16.37% |
| 2016-12-31 | 8.85% |
| 2016-09-30 | 18.51% |
| 2016-06-30 | 19.94% |
| 2016-03-31 | 22.04% |
| 2015-12-31 | 14.80% |
| 2015-09-30 | 9.47% |
| 2015-06-30 | 15.13% |
| 2015-03-31 | 18.02% |
| 2014-12-31 | 17.53% |
| 2014-09-30 | 17.47% |
| 2014-06-30 | 15.65% |
| 2014-03-31 | 17.10% |
| 2013-12-31 | 18.61% |
| 2013-09-30 | 17.74% |
| 2013-06-30 | 16.14% |
| 2013-03-31 | 20.00% |
| 2012-12-31 | 22.47% |
| 2012-09-30 | 21.93% |
| 2012-06-30 | 18.59% |
| 2012-03-31 | 23.23% |
| 2011-12-31 | 19.66% |
| 2011-09-30 | 18.50% |
| 2011-06-30 | 19.25% |
| 2011-03-31 | 19.09% |
| 2010-12-31 | 15.01% |
| 2010-09-30 | 21.82% |
| 2010-06-30 | -26.44% |
| 2010-03-31 | 19.74% |
| 2009-12-31 | 22.46% |
| 2009-09-30 | 20.37% |
| 2009-06-30 | 20.01% |
| 2009-03-31 | 18.15% |
| 2008-12-31 | 18.82% |
| 2008-09-30 | 18.98% |
| 2008-06-30 | 16.13% |
| 2008-03-31 | 15.29% |
| 2007-12-31 | 15.76% |
| 2007-09-30 | 14.36% |
| 2007-06-30 | 13.22% |
| 2007-03-31 | 19.39% |
| 2006-12-31 | 16.20% |
| 2006-09-30 | 37.74% |
| 2006-06-30 | 15.22% |
| 2006-03-31 | 10.39% |
| 2005-12-31 | 18.34% |
| 2005-09-30 | 37.41% |
| 2005-06-30 | 15.11% |
| 2005-03-31 | 18.97% |
| 2004-12-31 | 18.91% |
| 2004-09-30 | 16.42% |
| 2004-06-30 | 15.59% |
| 2004-03-31 | 18.98% |
| 2003-12-31 | 18.38% |
| 2003-09-30 | 17.31% |
| 2003-06-30 | 14.62% |
| 2003-03-31 | 19.70% |
| 2002-12-31 | 18.43% |
| 2002-09-30 | 17.83% |
